Ignite Creation Date:
2024-05-05 @ 7:21 PM
Last Modification Date:
2024-10-26 @ 9:47 AM
Study NCT ID:
NCT00650793
Status:
COMPLETED
Last Update Posted:
2011-06-08
First Post:
2008-03-31
Brief Title:
A 52-week Open-label Extension Study Following a 6-week Double-blind Placebo- and Active- Controlled Study R076477-SCH-303 to Evaluate the Safety and Tolerability of Paliperidone ER in Subjects With Schizophrenia
Sponsor:
Organization:
Johnson Johnson Pharmaceutical Research Development LLC